[PDF] Top 20 The case for a rational genome-based vaccine against malaria

... effective malaria vaccine has been disappointing. The premise of rational vaccine design is to induce the desired immune response against the key pathogen antigens or epitopes targeted ... See full document

... accepted rational approach to vaccine design and target selection for malaria or any other complex path- ...a rational approach to malaria vaccine design capable of exploiting ... See full document

... We have successfully demonstrated that the LCP delivery system usually used for production of antibodies can also induce strong IFN-γ production as a correlate of T cell activity. The cytokine production stimulated by ... See full document

... of malaria in older subjects who did not receive SMC ...national malaria control programmes and from ...of malaria parasites carry- ing markers of resistance to SP at the end of the malaria ... See full document

... RTS,S vaccine is currently the focus of decision- making by WHO, and depending on their recommen- dation, other stakeholders such as Gavi, the vaccine alliance, and national malaria control ... See full document

... the case definition. In this particular example, for a case definition of fever and > 3,000 p/ml, the VE without measurement error would be 50%, but, based only on the uncertainty associated with ... See full document

... HPS vaccine and also demonstrate the potential value of a postexposure immunoprophylactic to treat individuals after exposure, or potential exposure, to these highly lethal ... See full document

... and malaria combined, predominantly in third world ...of vaccine. In an attempt to develop a vaccine targeting the major human hookworm, Necator americanus, a B-cell peptide epitope was chosen from ... See full document

... deliver malaria vaccines as a means to achieving elimination. Malaria vaccine RTS, S is the most advanced candidate to undergo large scale Phase III evaluation in ...controlling malaria that ... See full document

... are based on the cultivation of the microorganism in laboratory conditions from which single components are isolated individually by using biochemical, microbiological and serological ...any case, only a ... See full document

... protection against murine ...the vaccine regimen based on CS14K prime/MVA-CS boost inhibits the liver stage development of the parasite in mice when challenged with a high dose of ... See full document

... this case, however, after only two rounds a virtually homogeneous selectant population was obtained, in which each of twelve individually characterized clones displayed the peptide 8-mer, ... See full document

... this vaccine candidate is Pichia pastoris expressed AMA1 with both FVO and 3D7 strains of ...AMA-C1/Alhydrogel, vaccine trials resulted in low titres of anti-AMA1 anti- bodies and little response in the ... See full document

... a malaria vaccine There are a number of possible models, which could be used for malaria vaccines, based on the policy-making experience described ...first, based upon the HPV model, is ... See full document

... a vaccine that targets the sporozoite and liver stages protects against blood-stage disease remains ...protection against clinical malaria by temporarily reducing the number of merozoites ... See full document

... In case of epitope, the histidine residue at the first position and the tyrosine residue in 9th position were seen to be very much flexible, as these residues were resulted with highest RMSD and RMSF (Figure ... See full document

... this case, the option of stopping transmission by vaccination with live poliovirus vaccine will not be ...the genome of NDV, a negative-strand RNA virus with mucosal ...antipoliovirus vaccine. ... See full document

... peptide based covalent cysteine protease ...the malaria genome contains more than one cysteine protease and that falcipain-1 is not the most important contributor to hemo- globin ... See full document

... responses against the CS ...endemic malaria region. In conclusion, the combination of Ad35.CS, a vaccine based on a rare serotype adenovirus, with ...protection against malaria, ... See full document

... In order to bring down the price of nets even further, PSI proposed creating competition in the producer market. By promising a market and providing insecticide sachets for free, the NGO convinced Arusha-based ... See full document